Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Rubin Steven D, Director. Director active across 6 companies, notably Red Violet, Inc.. Aggregated, 17 disclosures have been published. Split: 5 buys · 1 sell. Total volume traded: €402k. Activity tracked since 25 May 2023. The latest transaction was disclosed on 7 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Rubin Steven D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Rubin Steven D is Administrateur and has 16 filings in total. In the 16 recent filings we hold, they span 2021-09-27 to 2026-07-28, with buys of EUR 46055 and sells of EUR 355867. These recent filings concern Red Violet, Inc., Opko Health, INC., Entera Bio Ltd., Eloxx Pharmaceuticals, Inc., Cocrystal Pharma, Inc. and ChromaDex Corp.